Folgen
Rodrigo A Bressan
Rodrigo A Bressan
Professor Adjunto Livre Docente, Universidade Federal de São Paulo
Bestätigte E-Mail-Adresse bei unifesp.br
Titel
Zitiert von
Zitiert von
Jahr
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...
Nature 604 (7906), 502-508, 2022
12962022
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
9622017
Cannabis use before age 15 and subsequent executive functioning
MA Fontes, KI Bolla, PJ Cunha, PP Almeida, F Jungerman, RR Laranjeira, ...
The British Journal of Psychiatry 198 (6), 442-447, 2011
3722011
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ...
Molecular psychiatry 11 (2), 118-119, 2006
3492006
The role of dopamine in reward and pleasure behaviour–review of data from preclinical research
RA Bressan, JA Crippa
Acta Psychiatrica Scandinavica 111, 14-21, 2005
3442005
A general psychopathology factor (P factor) in children: Structural model analysis and external validation through familial risk and child global executive function.
MM Martel, PM Pan, MS Hoffmann, A Gadelha, MC do Rosário, JJ Mari, ...
Journal of abnormal psychology 126 (1), 137, 2017
2872017
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia bulletin 40 (4), 729-736, 2014
2722014
High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results
GA Salum, A Gadelha, PM Pan, TS Moriyama, AS Graeff‐Martins, ...
International journal of methods in psychiatric research 24 (1), 58-73, 2015
1922015
Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
WHL Pinaya, A Gadelha, OM Doyle, C Noto, A Zugman, Q Cordeiro, ...
Scientific reports 6 (1), 38897, 2016
1832016
The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil
WS Ribeiro, JJ Mari, MI Quintana, ME Dewey, S Evans-Lacko, LMP Vilete, ...
PloS one 8 (5), e63545, 2013
1722013
Impact of childhood stress on psychopathology
E Brietzke, M Kauer-Sant'anna, A Jackowski, R Grassi-Oliveira, J Bucker, ...
Brazilian Journal of Psychiatry 34, 480-488, 2012
1562012
Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial
MQ Hoexter, FL de Souza Duran, CC D'alcante, DD Dougherty, ...
Neuropsychopharmacology 37 (3), 734-745, 2012
1492012
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients
RA Bressan, K Erlandsson, HM Jones, R Mulligan, RJ Flanagan, PJ Ell, ...
American Journal of Psychiatry 160 (8), 1413-1420, 2003
1452003
Ventral striatum functional connectivity as a predictor of adolescent depressive disorder in a longitudinal community-based sample
PM Pan, JR Sato, GA Salum, LA Rohde, A Gadelha, A Zugman, J Mari, ...
American Journal of Psychiatry 174 (11), 1112-1119, 2017
1412017
Structural validity and reliability of the Positive and Negative Affect Schedule (PANAS): evidence from a large Brazilian community sample
HW Carvalho, SB Andreoli, DR Lara, CJ Patrick, MI Quintana, RA Bressan, ...
Revista Brasileira de Psiquiatria 35 (2), 169-172, 2013
1412013
Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis
C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ...
International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015
1362015
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ...
Psychopharmacology 197, 401-408, 2008
1342008
Towards a multifactorial approach for prediction of bipolar disorder in at risk populations
E Brietzke, RB Mansur, JK Soczynska, F Kapczinski, RA Bressan, ...
Journal of affective disorders 140 (1), 82-91, 2012
1332012
Bitopertin in negative symptoms of schizophrenia—results from the phase III FlashLyte and DayLyte studies
D Bugarski-Kirola, T Blaettler, C Arango, WW Fleischhacker, G Garibaldi, ...
Biological psychiatry 82 (1), 8-16, 2017
1232017
Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia
RA Bressan, DC Costa, HM Jones, PJ Ell, LS Pilowsky
Schizophrenia Research 56 (1-2), 31-36, 2002
1212002
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20